Pharmacy legislation: public protector or professional hindrance?

Area of Science:

• Pharmaceutical Law
• Medicinal Chemistry
• Pharmacology

Background:

• Pharmacy practice has evolved from medication compounding to include roles like pharmacist prescribing.
• Medication supply remains a central activity for most pharmacists.
• Regulation of pharmacy transitioned from the Royal Pharmaceutical Society of Great Britain (RPSGB) to the General Pharmaceutical Council (GPC) in 2010.

Purpose of the Study:

• To analyze the implications of the R. v Lee case on pharmacy practice and regulation.
• To examine the impact of prosecuting pharmacists for medication supply errors under the Medicines Act 1968.
• To assess whether current legal approaches are counterproductive to professional learning and public safety.

Main Methods:

• Legal case analysis (R. v Lee).
• Examination of the Medicines Act 1968, specifically sections 64 and 85.
• Review of regulatory changes concerning the General Pharmaceutical Council and RPSGB.

Main Results:

• The R. v Lee case involved a pharmacist prosecuted for a medication supply error, initially for manslaughter, later under the Medicines Act 1968.
• Offenses under sections 64 and 85 of the Medicines Act are absolute offenses with no due diligence defense.
• An appeal clarified section 85(5), but prosecutions under section 64 remain possible, potentially deterring error reporting and learning.

Conclusions:

• Prosecuting pharmacists for medication supply errors under absolute offenses may be counterproductive.
• The threat of criminal conviction under section 64 of the Medicines Act could stifle the profession's ability to learn from dispensing errors.
• Re-evaluation of legal frameworks is needed to balance public protection with professional development and error management in pharmacy.